Arsenal Medical Stock

Arsenal Medical develops novel products that improve local therapy for injuries and diseases.

Sign up today and learn more about Arsenal Medical Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Arsenal Medical Stock

Arsenal Medical uses conventional biomaterials in unconventional ways to develop novel products that improve local therapy for injury and disease. The company is advancing multiple preclinical programs based on both its two proprietary technology platforms: its therapeutic foam and AxioCore, a novel, high-throughput nanofiber technology. Arsenal Medical is supported by venture funding, as well as grants from the Department of Defense, National Institute of Standards and Technology’s Technology Innovation Program (NIST-TIP) and the Bill & Melinda Gates Foundation. Its investors include Polaris Venture Partners, North Bridge Venture Partners and Intersouth Partners.

Funding History

April 2009$8.2M
January 2010$2.0M
January 2010$2.0M
March 2010$1.0M
May 2010$10.0M
August 2010$3.0M
September 2011$3.0M
October 2012$3.0M
August 2013$4.0M
June 2015$16.0M


President and CEO

R. Scott Rader

Founder and Chairman

Carmichael Roberts

President and Chief Executive Officer

James J. Barry


Robert Langer

Director of Materials Science and Engineering

Upma Sharma

Vice President, Research and Development

Toby Freyman


James J. Barry

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: